Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.

Kathleen Coughlin is committed to removing obstacles for cancer patients, focusing on transportation, insurance, and ...

The first patient has been enrolled in the ARID II trial evaluating Voro Urologic Scaffold to improve continence after ...

CURE spoke with John Crispino, the director of the division of experimental hematology at St. Jude Children’s Research Hospital.

After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.